Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy

Retrieved on: 2024-08-06 19:45:44

Tags for this article:

Click the tags to see associated articles and topics

Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy. View article details on hiswai:

Excerpt

See Also: Neuralink Implants Brain Device In Second Human, Elon Musk Plans 8 More Trials This Year. As a result, the company expects Roctavian to ...

Article found on: www.tradingview.com